195 related articles for article (PubMed ID: 11960266)
1. Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaints.
Heldal D; Brinch L; Tjønnfjord G; Solheim BG; Egeland T; Gadeholt G; Albrechtsen D; Aamodt G; Evensen SA
Bone Marrow Transplant; 2002 Mar; 29(6):479-86. PubMed ID: 11960266
[TBL] [Abstract][Full Text] [Related]
2. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
3. [Collection of peripheral hematopoietic stem cells for transplantation from volunteer donors--siblings of the patients].
Mayer J; Korístek Z; Krahulová M; Pospísil Z; Doubek M; Klabusay M; Brychtová Y; Hoffová V; Cernanská J; Krejcí M; Vorlícek J
Vnitr Lek; 2001 Sep; 47 Suppl 1():15-28. PubMed ID: 11693058
[TBL] [Abstract][Full Text] [Related]
4. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.
de la Rubia J; de Arriba F; Arbona C; Pascual MJ; Zamora C; Insunza A; Martínez D; Paniagua C; Díaz MA; Sanz MA
Haematologica; 2008 May; 93(5):735-40. PubMed ID: 18387976
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
8. Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors.
Pulsipher MA; Nagler A; Iannone R; Nelson RM
Pediatr Blood Cancer; 2006 Apr; 46(4):422-33. PubMed ID: 16411207
[TBL] [Abstract][Full Text] [Related]
9. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study.
Beelen DW; Ottinger H; Kolbe K; Pönisch W; Sayer HG; Knauf W; Stockschläder M; Scheid C; Schaefer UW
Ann Hematol; 2002 Dec; 81(12):701-9. PubMed ID: 12483366
[TBL] [Abstract][Full Text] [Related]
10. Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.
López-Holgado N; Pata C; Villarón E; Sánchez-Guijo F; Alberca M; Martín A; Corral M; Sánchez-Abarca I; Pérez-Simón JA; San Miguel JF; del Cañizo MC
Haematologica; 2005 Mar; 90(3):353-9. PubMed ID: 15749668
[TBL] [Abstract][Full Text] [Related]
11. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
[TBL] [Abstract][Full Text] [Related]
12. Differences between graft product and donor side effects following bone marrow or stem cell donation.
Favre G; Beksaç M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szer J; Bradstock K; Buzyn A; Matcham J; Gratwohl A; Schmitz N;
Bone Marrow Transplant; 2003 Nov; 32(9):873-80. PubMed ID: 14561987
[TBL] [Abstract][Full Text] [Related]
13. Harvesting peripheral blood progenitor cells from healthy donors with a short course of recombinant human granulocyte-colony-stimulating factor.
Martino M; Morabito F; Callea I; Pontari A; Irrera G; Pucci G; Dattola A; Messina G; Console G; Iacopino P
Transfus Med; 2005 Aug; 15(4):323-8. PubMed ID: 16101811
[TBL] [Abstract][Full Text] [Related]
14. Unusual adverse events following peripheral blood stem cell (PBSC) mobilisation using granulocyte colony stimulating factor (G-CSF) in healthy donors.
Hilbe W; Nussbaumer W; Bonatti H; Thaler J; Niederwieser D; Nachbaur D
Bone Marrow Transplant; 2000 Oct; 26(7):811-3. PubMed ID: 11042668
[TBL] [Abstract][Full Text] [Related]
15. Mobilized blood cells vs bone marrow harvest: experience compared in 171 donors with particular reference to pain and fatigue.
Karlsson L; Quinlan D; Guo D; Brown C; Selinger S; Klassen J; Russell JA
Bone Marrow Transplant; 2004 Apr; 33(7):709-13. PubMed ID: 14755321
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study.
Tassi C; Tazzari PL; Bonifazi F; Giudice V; Nannetti A; Ricci F; Rizzi S; Bandini G; Conte R
Bone Marrow Transplant; 2005 Aug; 36(4):289-94. PubMed ID: 15968277
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
18. Blood stem cell procurement: donor safety issues.
Anderlini P; Przepiorka D; Körbling M; Champlin R
Bone Marrow Transplant; 1998 Jun; 21 Suppl 3():S35-9. PubMed ID: 9712491
[TBL] [Abstract][Full Text] [Related]
19. Impact of stem cell donation modality on normal donor quality of life: a prospective randomized study.
Kennedy GA; Morton J; Western R; Butler J; Daly J; Durrant S
Bone Marrow Transplant; 2003 Jun; 31(11):1033-5. PubMed ID: 12774056
[TBL] [Abstract][Full Text] [Related]
20. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]